Eterna Therapeutics (ERNA) Live Share Price, Invest From India

Eterna Therapeutics Stock Performance

as on September 19, 2026 at 2:15 pm IST

Day's Low
Day's High
$3.82
Day's Price Range
$3.88
$3.83
0.26%
Downside
1.31%
Upside
52 Week's Low
52 Week's High
$3.18
52-Week Price Range
$71.50
$3.83
16.90%
Downside
1766.78%
Upside

Eterna Therapeutics share price movements today

Previous Close: $3.76
Open: $3.87
Volume: 106.9K
Market Cap: $4.4M
Day's Low - High: $3.82 - $3.88
52 Week Low - High: $3.18 - $71.50

Eterna Therapeutics Historical Returns

1 Month Return: -15.12 %
3 Month Return: -39.35 %
1 Year Return: -88.69 %
3 Year Return: -99.51 %
5 Year Return: 0 %

Eterna Therapeutics Stock Fundamentals & Key Indicators

Check Eterna Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.4M

EPS (TTM)

-18.85

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.2

Industry PE ratio

-2.37

PEG Ratio

-0.0012788077986625125

EBITDA

-17.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-305.85%

Eterna Therapeutics Stock Valuation

Track how Eterna Therapeutics P/E has moved over time to understand its valuation trends.

Eterna Therapeutics in the last 5 years

Overview
Trends

Lowest (-22.10x)

March 31, 2022

Industry (-2.37x)

December 31, 2025

Today (-0.54x)

December 31, 2025

Highest (-0.54x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.54x

Eterna Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Eterna Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Eterna Therapeutics	SELL	$4.4M	NA	-0.2	0.00%	0.00%
Moderna	BUY	$63.1B	-63.24%	-19.81	-12.57%	0.00%
Vertex Pharmaceuticals	BUY	$130.1B	174.21%	29.81	86.04%	0.00%
Regeneron	BUY	$79.7B	21.1%	18.48	84.86%	0.48%

Stock Returns calculator for Eterna Therapeutics Stock including INR - Dollar returns

The Eterna Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Eterna Therapeutics investment value today

Current value as on today

₹12,507

Returns

-₹87,493

(-87.49%)

Returns from Eterna Therapeutics Stock

-₹88,481 (-88.48%)

Dollar Impact

₹988 (+0.99%)

Analyst Recommendation on Eterna Therapeutics Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Eterna Therapeutics. Average target price of $30

Eterna Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Eterna Therapeutics.

What analysts predicted

87.23%UPSIDE

Target Price

$30

Current Price

$3.83

Analyzed by

6 Analysts

Target

$30.00

Eterna Therapeutics target price $30, a slight upside of 87.23% compared to current price of $3.83. According to 6 analysts rating.

Indian Investors' Interest in Eterna Therapeutics Stock

Search interest for Eterna Therapeutics Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 21, 2026 to September 20, 2026

Change:-4% versus previous 30 day period

Eterna Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	0	0	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	0	-
Operating Income	-5	-4	-2	-2	-2	-2	-1	-2	-3	-4
EBITDA	-5	-4	-24	-2	-8	-3	-1	-6	-5	-4
Interest Expense	0	0	1	3	-	-	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	-
Income Before Tax	-6	-5	-26	-5	-8	-3	-1	-1	-5	-4
Income Tax Expense	0	0	0	0	0	0	0	0	0	-
Net Income	-6	-5	-26	-5	-8	-3	-1	-1	-5	-4
Net Profit Margin	-1180.85%	-102.13%	112.32%	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Eterna Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Mar 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	21	23	19	-	-	-	0	0	-
Gross Profit	14	14	11	0	-	-	0	0	-
Operating Income	-1	0	-1	-7	-113	-33	-21	-15	-9
EBITDA	0	3	1	-26	-121	-24	-19	-36	-13
Interest Expense	0	0	0	0	0	0	0	6	0
Depreciation	2	2	3	0	0	0	1	1	0
Income Before Tax	-1	0	-2	-26	-122	-24	-21	-44	-14
Income Tax Expense	0	0	0	-	0	0	0	0	0
Net Income	-1	0	-2	11	-122	-24	-21	-44	-14
Net Profit Margin	66.68%	64.07%	60.40%	0.00%	0.00%	0.00%	-247.06%	83.51%	0.00%

Eterna Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-6	-5	-26	-5	-8	-3	-1	-1	-5	-4
Operating Cash Flow	-3	-2	-6	-3	-2	-2	-1	-1	-2	-4
Investing Cash Flow	0	0	0	-	-	-	0	0	0	0
Financing Cash Flow	1	0	3	1	2	4	0	-	9	0
Change in Cash	-2	-2	1	-2	0	2	-1	-1	7	-4

Eterna Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Mar 2022	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	0	-2	-26	-122	-24	-21	-44	-14
Operating Cash Flow	0	1	2	-8	-23	-20	-20	-15	-7
Investing Cash Flow	-1	-1	-1	0	-22	0	0	0	0
Financing Cash Flow	-1	0	-1	4	61	19	16	6	7
Change in Cash	-2	0	0	-1	15	-1	-3	-9	0

Mutual Funds that own Eterna Therapeutics Stock

Check out the Mutual Funds with significant holdings in Eterna Therapeutics.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	1.137091%	18562

Global Institutional Holdings in Eterna Therapeutics

Funds	Holdings
Vanguard	0.35%

Insights on Eterna Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 48.8% return, outperforming this stock by 148.3%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 598.8%
NEGATIVE IMPACT
Price Dip
In the last 1 year, ERNA stock has moved down by -88.5%

About Eterna Therapeutics

Ernexa Therapeutics Inc. is a biotechnology firm currently in its preclinical development phase, specializing in the creation of therapeutic interventions using induced mesenchymal stem cells (iMSCs). The company's primary focus lies in addressing solid tumor cancers and a range of autoimmune diseases. Its flagship candidate, ERNA-101, is an allogeneic iMSC designed to release pro-inflammatory cytokines, namely IL-7 and IL-15, intended for the treatment of ovarian cancer. Additionally, Ernexa is developing ERNA-102, an iMSC product engineered to secrete the anti-inflammatory cytokine IL-10, aimed at managing rheumatoid arthritis. The company has a licensing arrangement in place with Factor Bioscience Limited. Established in 2018, this Cambridge, Massachusetts-based entity operated as Eterna Therapeutics Inc. until its rebranding to Ernexa Therapeutics in March 2025.

Organisation	Eterna Therapeutics
Headquarters	10355 Science Center Drive, Cambridge, MA, 02141, US
Industry	Biotechnology
CEO	Sanjeev Luther
E-voting on shares	Click here to vote

Key Management of Eterna Therapeutics

Name	Title
Mr. Sanjeev Luther	CEO, President & Director

FAQs

What is Eterna Therapeutics share price today?

Eterna Therapeutics share price today is $3.83 as on September 19, 2026 at 8:45 am IST at the close of the market. Eterna Therapeutics share today touched a day high of $3.88 and a low of $3.82.

What is the 52 week high and 52 week low for Eterna Therapeutics share?

Eterna Therapeutics share touched a 52 week high of $71.50 on January 1, 1970 and a 52 week low of $3.18 on January 1, 1970. Eterna Therapeutics stock price today i.e. September 19, 2026 at 8:45 am IST is closed at $3.83,which is 94.64% down from its 52 week high and 20.33% up from its 52 week low.

What is Eterna Therapeutics's market capitalisation today?

Eterna Therapeutics market capitalisation is $0.00T as on September 19, 2026 at 8:45 am IST.

How to invest in Eterna Therapeutics Stock (ERNA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Eterna Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Eterna Therapeutics Shares that will get you 0.3916 shares as per Eterna Therapeutics share price of $3.83 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Eterna Therapeutics Stock (ERNA) from India?

Indian investors can start investing in Eterna Therapeutics (ERNA) shares with as little as ₹95.88 or $1 (as of September 20, 2026 at 10:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Eterna Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 20, 2026 at 10:42 pm IST). Based on Eterna Therapeutics share’s latest price of $3.83 as on September 19, 2026 at 8:45 am IST, you will get 2.6110 shares of Eterna Therapeutics. Learn more about fractional shares .